[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR112013029778A2 - composição farmacêutica que compreende fexofenadina - Google Patents

composição farmacêutica que compreende fexofenadina

Info

Publication number
BR112013029778A2
BR112013029778A2 BR112013029778A BR112013029778A BR112013029778A2 BR 112013029778 A2 BR112013029778 A2 BR 112013029778A2 BR 112013029778 A BR112013029778 A BR 112013029778A BR 112013029778 A BR112013029778 A BR 112013029778A BR 112013029778 A2 BR112013029778 A2 BR 112013029778A2
Authority
BR
Brazil
Prior art keywords
fexofenadine
pharmaceutical composition
avaible
abstract
pharmaceutical
Prior art date
Application number
BR112013029778A
Other languages
English (en)
Inventor
Kum Prasad
Nilesh Jaiswal
Praveen Khullar
Sudhakara Rao Badabhagni
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of BR112013029778A2 publication Critical patent/BR112013029778A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)

Abstract

abstract not avaible
BR112013029778A 2011-05-20 2012-05-16 composição farmacêutica que compreende fexofenadina BR112013029778A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1727CH2011 2011-05-20
US201161499856P 2011-06-22 2011-06-22
EP11305923 2011-07-13
PCT/EP2012/059147 WO2012159960A1 (en) 2011-05-20 2012-05-16 Pharmaceutical composition comprising fexofenadine

Publications (1)

Publication Number Publication Date
BR112013029778A2 true BR112013029778A2 (pt) 2017-01-17

Family

ID=47216626

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013029778A BR112013029778A2 (pt) 2011-05-20 2012-05-16 composição farmacêutica que compreende fexofenadina

Country Status (18)

Country Link
US (1) US20140073670A1 (pt)
EP (1) EP2709600A1 (pt)
JP (1) JP2014513708A (pt)
KR (1) KR20140037876A (pt)
CN (1) CN103687592A (pt)
AR (1) AR086491A1 (pt)
BR (1) BR112013029778A2 (pt)
CA (1) CA2835912A1 (pt)
CO (1) CO6831986A2 (pt)
CR (1) CR20130591A (pt)
EA (1) EA201391742A1 (pt)
EC (1) ECSP13013095A (pt)
IL (1) IL229417A0 (pt)
MA (1) MA35400B1 (pt)
MX (1) MX2013013575A (pt)
SG (1) SG195015A1 (pt)
UY (1) UY34080A (pt)
WO (1) WO2012159960A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015003109A1 (en) * 2013-07-03 2015-01-08 R.P. Scherer Technologies, Llc Capsule formulation comprising fexofenadine
US9504656B2 (en) * 2013-10-21 2016-11-29 Banner Life Sciences, LLC Pharmaceutical compositions for poorly soluble active ingredients
CN104133014B (zh) * 2014-07-16 2015-09-16 广州法尔麦兰药物技术有限公司 一种考察布洛伪麻缓释制剂释放度的方法
CN107847496A (zh) * 2015-02-20 2018-03-27 英仕柏集团有限责任公司 含有非索非那丁的软明胶胶囊

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929605A (en) 1987-10-07 1990-05-29 Merrell Dow Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol derivatives
CN1259053A (zh) * 1997-04-11 2000-07-05 藤泽药品工业株式会社 药物组合物
RU2197967C2 (ru) 1997-08-14 2003-02-10 Авентис Фармасьютикалз, Инк. Способ повышения биологической доступности фексофенадина и его производных
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
WO2001076582A1 (fr) * 2000-04-05 2001-10-18 Shionogi & Co., Ltd. Micro-emulsions huile dans eau contenant des composes tricycliques ou des preconcentres de ceux-ci
CZ20033341A3 (cs) * 2001-06-21 2004-10-13 Pfizeráproductsáinc Samoemulgující se kompozice inhibitorů přenosového proteinu cholesterylesteru
CA2471241A1 (en) * 2001-12-20 2003-07-03 Bernard Charles Sherman Pharmaceutical compositions comprising a cyclosporin, a hydrophilic surfactant and a lipophilic surfactant
GB2391473B (en) * 2002-08-02 2004-07-07 Satishchandra Punambhai Patel Pharmaceutical compositions
EP1624862B1 (en) * 2003-05-08 2014-12-31 Nektar Therapeutics Particulate materials
JP2005075804A (ja) * 2003-09-03 2005-03-24 Toyo Capsule Kk メナテトレノン含有医薬組成物
WO2005062722A2 (en) * 2003-11-21 2005-07-14 Sun Pharmaceutical Industries Limited Fexofenadine containing pharmaceutical formulation

Also Published As

Publication number Publication date
SG195015A1 (en) 2013-12-30
AR086491A1 (es) 2013-12-18
US20140073670A1 (en) 2014-03-13
MX2013013575A (es) 2014-09-15
IL229417A0 (en) 2014-01-30
EA201391742A1 (ru) 2014-04-30
EP2709600A1 (en) 2014-03-26
WO2012159960A1 (en) 2012-11-29
CO6831986A2 (es) 2014-01-10
CR20130591A (es) 2014-05-07
MA35400B1 (fr) 2014-09-01
ECSP13013095A (es) 2014-01-31
CN103687592A (zh) 2014-03-26
JP2014513708A (ja) 2014-06-05
UY34080A (es) 2013-01-03
KR20140037876A (ko) 2014-03-27
CA2835912A1 (en) 2012-11-29

Similar Documents

Publication Publication Date Title
BR112013028512A2 (pt) cápsula
BR112013023241A2 (pt) melhorias para entidades biológicas imobilizadas
BR112014001219A2 (pt) perfume
BR112013028235A2 (pt) refrigerador
DK2694038T3 (da) Farmaceutisk sammensætning
BR112013028281A2 (pt) compostos e composições para inibição de nampt
CO6980625A2 (es) Composiciones que generan perácidos
CR20130406A (es) Composiciones farmacéuticas que comprenden anticuerpos humanos frente a pcsk9
BR112014003052A2 (pt) composições farmacêuticas
UY34779A (es) Anticuerpos anti-il-23 y composiciones farmacéuticas que los contienen
BR112013025866A2 (pt) formulações com viscosidade reduzida
CO6930364A2 (es) Composiciones farmaceúticas que comprenden 40-o-(2-hidroxi) etil - rapamicina
ES2985024T3 (es) Nueva composición farmacéutica
UY33906A (es) Composiciones herbicidas que comprenden topramezona
BR112014002403A2 (pt) composição dentifrícia não aquosa
BR112013028039A2 (pt) composição de cimento
BR112013029784A2 (pt) bomba
BR112014014536A2 (pt) um inalador compreendendo uma composição contendo tiotrópio
BR112013028251A2 (pt) polipeptídeo
DK2897594T3 (da) Farmaceutisk sammensætning
BR112013026462A2 (pt) protetor de pé
UY34800A (es) Combinaciones farmacéuticas que contienen un inhibidor de 11-beta-hidroxiesteroide dehidrogenasa-1 útil en trastornos metabólicos
BR112014005877A2 (pt) cápsula para preparar uma bebida
BR112013032555A2 (pt) composição selante híbrida
CO6920289A2 (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]